Your browser doesn't support javascript.
loading
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
Sax, Paul E; Tierney, Camlin; Collier, Ann C; Daar, Eric S; Mollan, Katie; Budhathoki, Chakra; Godfrey, Catherine; Jahed, Nasreen C; Myers, Laurie; Katzenstein, David; Farajallah, Awny; Rooney, James F; Ha, Belinda; Woodward, William C; Feinberg, Judith; Tashima, Karen; Murphy, Robert L; Fischl, Margaret A.
Affiliation
  • Sax PE; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. psax@partners.org
J Infect Dis ; 204(8): 1191-201, 2011 Oct 15.
Article in En | MEDLINE | ID: mdl-21917892

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenine / Dideoxynucleosides / HIV Infections / Lamivudine / Anti-HIV Agents / Deoxycytidine / Organophosphonates Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 2011 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenine / Dideoxynucleosides / HIV Infections / Lamivudine / Anti-HIV Agents / Deoxycytidine / Organophosphonates Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 2011 Type: Article Affiliation country: United States